Scarica l'app Stockscreener
2.75
4.17%
0.11
Pre-mercato:
2.71
-0.04
-1.45%
Cns Pharmaceuticals Inc Azioni (CNSP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
35.03%
3.2534
|
2.4094 | 4.3377 | 3.20 | 5.6289 |
| Operating Income/Loss |
35.03%
-3.2534
|
-2.4094 | -4.3377 | -3.20 | -5.6289 |
| Nonoperating Income/Loss |
1.40%
0.0349
|
0.0344 | 0.0363 | 0.0237 | 0.023 |
| Income/Loss From Continuing Operations Before Tax |
35.52%
-3.2185
|
-2.375 | -4.3013 | -3.1764 | -5.6059 |
| Income/Loss From Continuing Operations After Tax |
35.52%
-3.2185
|
-2.375 | -4.3013 | -3.1764 | -5.6059 |
|
Net Income/Loss
|
35.52%
-3.2185
|
-2.375 | -4.3013 | -3.1764 | -5.6059 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
50.99%
0.5589
|
0.3701 | 2.7266 | -7.1991 | 22.18 |
| Diluted Average Shares |
50.99%
0.5589
|
0.3701 | 2.7266 | -7.1991 | 22.18 |
| Basic Earnings Per Share |
10.28%
-5.76
|
-6.42 | -1.58 | -37.33 | -0.25 |
| Diluted Earnings Per Share |
10.28%
-5.76
|
-6.42 | -1.58 | -37.33 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):